Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Carmen E. Gómez"'
Autor:
Beatriz Perdiguero, Benedikt Asbach, Carmen E. Gómez, Josef Köstler, Susan W. Barnett, Marguerite Koutsoukos, Deborah E. Weiss, Anthony D. Cristillo, Kathryn E. Foulds, Mario Roederer, David C. Montefiori, Nicole L. Yates, Guido Ferrari, Xiaoying Shen, Sheetal Sawant, Georgia D. Tomaras, Alicia Sato, William J. Fulp, Raphael Gottardo, Song Ding, Jonathan L. Heeney, Giuseppe Pantaleo, Mariano Esteban, Ralf Wagner
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
To control HIV infection there is a need for vaccines to induce broad, potent and long-term B and T cell immune responses. With the objective to accelerate and maintain the induction of substantial levels of HIV-1 Env-specific antibodies and, at the
Externí odkaz:
https://doaj.org/article/6036c61a4c684d169531306cb6b2b597
Autor:
Mauro Di Pilato, Miguel Palomino-Segura, Ernesto Mejías-Pérez, Carmen E. Gómez, Andrea Rubio-Ponce, Rocco D’Antuono, Diego Ulisse Pizzagalli, Patricia Pérez, Raphael Kfuri-Rubens, Alberto Benguría, Ana Dopazo, Iván Ballesteros, Carlos Oscar S. Sorzano, Andrés Hidalgo, Mariano Esteban, Santiago F. Gonzalez
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Neutrophils are innate immune cells involved in the elimination of pathogens and can also induce adaptive immune responses. Nα and Nβ neutrophils have been described with distinct in vitro capacity to generate antigen-specific CD8 T-cell r
Externí odkaz:
https://doaj.org/article/89b84f82228e4bf9963a98f0174b37ad
Autor:
María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders, Mariano Esteban
Publikováno v:
Vaccines, Vol 8, Iss 3, p 440 (2020)
Hepatitis C virus (HCV) represents a major global health challenge and an efficient vaccine is urgently needed. Many HCV vaccination strategies employ recombinant versions of the viral E2 glycoprotein. However, recombinant E2 readily forms disulfide-
Externí odkaz:
https://doaj.org/article/6f855dc5a67b4641aa075ea16b286ab4
Autor:
Patricia Pérez, María Q. Marín, Adrián Lázaro-Frías, Carlos Óscar S. Sorzano, Carmen E. Gómez, Mariano Esteban, Juan García-Arriaza
Publikováno v:
Vaccines, Vol 8, Iss 1, p 70 (2020)
Development of a safe and efficacious vaccine against the HIV/AIDS pandemic remains a major scientific goal. We previously described an HIV/AIDS vaccine based on the modified vaccinia virus Ankara (MVA) expressing HIV-1 gp120 and Gag-Pol-Nef (GPN) of
Externí odkaz:
https://doaj.org/article/18159ab25e6b4f1a84c461277eafe442
Autor:
Elvira Couto, Vicenç Diaz-Brito, Beatriz Mothe, Alberto C. Guardo, Irene Fernandez, Ainoa Ugarte, Flor Etcheverry, Carmen E. Gómez, Mariano Esteban, Judit Pich, Joan Albert Arnaiz, Juan Carlos López Bernaldo de Quirós, Christian Brander, Montserrat Plana, Felipe García, Lorna Leal
Publikováno v:
Vaccines, Vol 7, Iss 4, p 178 (2019)
There are few studies comparing the safety and immunogenicity of the same HIV immunogen in healthy volunteers and HIV-infected individuals. We analyzed demographics, adverse events (AEs), and immunogenicity against vaccinia virus in preventive (RISVA
Externí odkaz:
https://doaj.org/article/78463bed78a2438b8282d489ded9ca29
Autor:
María Q. Marín, Patricia Pérez, Carmen E. Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Juan García-Arriaza
Publikováno v:
Viruses, Vol 10, Iss 8, p 414 (2018)
Hepatitis C virus (HCV) represents a major global health problem for which a vaccine is not available. Modified vaccinia virus Ankara (MVA)-HCV is a unique HCV vaccine candidate based in the modified vaccinia virus Ankara (MVA) vector expressing the
Externí odkaz:
https://doaj.org/article/5e7afe06dd004ab6ab18c1350ca8fa4b
Autor:
Lorena Usero, Carlos Oscar S. Sorzano, Cristina Sánchez-Corzo, Montserrat Plana, Mariano Esteban, Felipe García, Laura Marcos-Villar, Laia Miralles, Beatriz Perdiguero, Lorna Leal, Carmen E. Gómez
Publikováno v:
Vaccines
Volume 9
Issue 9
Vaccines, Vol 9, Iss 959, p 959 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Volume 9
Issue 9
Vaccines, Vol 9, Iss 959, p 959 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Development of a vaccine against HIV remains a major target goal in the field. The recent success of mRNA vaccines against the coronavirus SARS-CoV-2 is pointing out a new era of vaccine designs against pathogens. Here, we have generated two types of
Autor:
Fernando Izquierdo, Almudena Alhambra, A. Magnet, Dolores Ollero, Carolina Hurtado-Marcos, Carmen del Aguila, Soledad Fenoy, María López Cano, Thiago Santos Gomes, Lucianna Vaccaro, Carmen E. Gómez, Sergio Llorens Berzosa, Carmen Pelaz, Santiago Salso, Beatriz Bellido Samaniego
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Repisalud
Instituto de Salud Carlos III (ISCIII)
Frontiers in Microbiology
Repisalud
Instituto de Salud Carlos III (ISCIII)
L. feeleii is one of the most frequent Legionella species isolated from natural pools of the central region of Spain. This study aimed to evaluate its ecology and to identify this Legionella species as a respiratory pathogen. A PCR assay for detectin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fd6b0f076bb24e6840642998995089
https://hdl.handle.net/20.500.12105/14232
https://hdl.handle.net/20.500.12105/14232
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Vaccines, Vol 9, Iss 243, p 243 (2021)
Vaccines
instname
Vaccines, Vol 9, Iss 243, p 243 (2021)
Vaccines
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants in different continents is causing a major concern in human global health. These variants have in common a higher transmissibility, becoming dominant within popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e665b1cb7aadd3b8916b5cf84f0b3b8
http://hdl.handle.net/10261/239058
http://hdl.handle.net/10261/239058
Autor:
Susana Guerra, Carlos Oscar S. Sorzano, Martina Becares, Carmen E. Gómez, Mariano Esteban, Michela Falqui, Beatriz Perdiguero, Juan García-Arriaza, María Q. Marín
Publikováno v:
J Virol
Induction of the endogenous innate immune system by interferon (IFN) triggers the expression of many proteins that serve like alarm bells in the body, activating an immune response. After a viral infection, one of the genes activated by IFN induction